IBS Treatment With H1-receptor Antagonists.
Phase of Trial: Phase IV
Latest Information Update: 21 May 2013
At a glance
- Drugs Ebastine (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 21 May 2013 Primary endpoint 'Clinical-response' has not been met according to results presented at Digestive Disease Week 2013.
- 21 May 2013 Results presented at Digestive Disease Week 2013.
- 21 May 2012 Actual patient number is 55 as reported by ClinicalTrials.gov.